ADUS
Analysis
On November 4, 2026, Barclays updated its outlook on Addus HomeCare Corporation, maintaining an 'Underweight' rating. The firm raised its price target for the company's shares to $101 from the previous $96. This adjustment represents a 5.2% increase in the target price, which the firm noted implies a potential downside of approximately 20.2% based on the stock's closing price on November 3, 2026.